PlainRecalls
FDA Drug Critical Class I Ongoing

ELCYS (cysteine hydrochloride injection), USP, 500 mg/10mL (50 mg/mL), 10x10 mL Single Dose Sterile Vials, For Intravenous Infusion Only, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial: NDC 51754-1007-1; Carton: 51754-1007-3).

Reported: November 29, 2023 Initiated: October 18, 2023 #D-0118-2024

Product Description

ELCYS (cysteine hydrochloride injection), USP, 500 mg/10mL (50 mg/mL), 10x10 mL Single Dose Sterile Vials, For Intravenous Infusion Only, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial: NDC 51754-1007-1; Carton: 51754-1007-3).

Reason for Recall

Presence of Particulate Matter: Silicone

Details

Recalling Firm
Exela Pharma Sciences LLC
Units Affected
38,200 vials
Distribution
Nationwide
Location
Lenoir, NC

Frequently Asked Questions

What product was recalled?
ELCYS (cysteine hydrochloride injection), USP, 500 mg/10mL (50 mg/mL), 10x10 mL Single Dose Sterile Vials, For Intravenous Infusion Only, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial: NDC 51754-1007-1; Carton: 51754-1007-3).. Recalled by Exela Pharma Sciences LLC. Units affected: 38,200 vials.
Why was this product recalled?
Presence of Particulate Matter: Silicone
Which agency issued this recall?
This recall was issued by the FDA Drug on November 29, 2023. Severity: Critical. Recall number: D-0118-2024.